Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours

Yada Kanjanapan, Prunella Blinman, Craig Underhill, Deme Karikios, Eva Segelov, Desmond Yip

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)

Abstract

People with cancer are vulnerable to increased morbidity and mortality from the coronavirus disease 2019 (COVID-19). COVID-19 vaccination is key to protecting the population of people with cancer from adverse outcomes of SARS-CoV-2 infection. The Medical Oncology Group of Australia aimed to address the considerations around COVID-19 vaccination in people with cancer, in particular, safety and efficacy of vaccination. The assessment of patients with generalised allergic reaction to anti-cancer therapy containing vaccine components and practical implementation of vaccination of people on active anti-cancer therapy are also discussed.

Original languageEnglish
Pages (from-to)955-959
Number of pages5
JournalInternal Medicine Journal
Volume51
Issue number6
DOIs
Publication statusPublished - Jun 2021

Keywords

  • cancer
  • COVID-19
  • immunosuppression
  • vaccination

Cite this